PMID: 8589354Jan 1, 1995Paper

Possible cause of primary graft non-function after orthotopic liver transplantation: a hypothesis with rat models

Journal of Gastroenterology and Hepatology
Kenji FujiwaraM Arai

Abstract

The cause of primary graft non-function after orthotopic liver transplantation (OLTX) is uncertain, but its clinical features are similar to fulminant hepatic failure with coagulopathy. In preserved livers, endothelial cell damage in the hepatic sinusoids is characteristic, indicating that fibrin deposition in the hepatic sinusoids, which can cause massive hepatic necrosis, might occur in the liver after OLTX. When rat liver was preserved in University of Wisconsin solution at 1 degree C, detachment of endothelial linings into sinusoidal lumens developed with fat-storing cell damage after 18 h. In this liver, hepatic macrophages were activated after reperfusion. Tissue factor activity in hepatic macrophages isolated from livers after OLTX was significantly increased compared to the control liver and this increase was enhanced by addition of endotoxin. In the preserved and transplanted livers, thrombomodulin expression in endothelial cells disappeared and fibrin deposition was seen in the hepatic sinusoids. Intravenous infusion therapy with antithrombin III attenuated liver injury 24 h after OLTX following preservation for 18 h. These results suggest that intravascular coagulation in the hepatic sinusoids associated with liver i...Continue Reading

References

Jul 1, 1988·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·W C Maddrey, D H Van Thiel
Jun 1, 1981·American Journal of Clinical Pathology·S M HsuH Fanger
Jan 1, 1994·Transplant International : Official Journal of the European Society for Organ Transplantation·M BreuerC Hammer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.